Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04479072 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Aspirin and Preeclampsia

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Mar 1, 2026 to Dec 1, 2026v12
  2. Primary completion date: Oct 1, 2025 to Mar 1, 2026
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    v11
  3. 2 versions Re-verified since Jun 13, 2024, no change to tracked fieldsv9-v10
  4. Primary completion date: Jan 1, 2026 to Oct 1, 2025
    • Study completion date: Feb 28, 2026 to Dec 31, 2025
    v8
  5. Re-verified, no change to tracked fieldsv7
Show 5 earlier versionsHide 5 earlier versions
  1. Secondary endpoints revised (5)
    • Study description expanded, about 4 words
    v6
  2. Eligibility criteria expanded, about 30 wordsv5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 1, 2021 to Feb 15, 2021
    • Site details revised
    v4
  4. Start date: Sep 1, 2020 to Feb 1, 2021
    • Primary completion date: Jul 31, 2025 to Jan 1, 2026
    • Study completion date: Aug 31, 2025 to Feb 28, 2026
    v3
  5. Secondary endpoints: details revised at 2 of 5 entriesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a single-center, double-blind, randomized, placebo-controlled clinical trial. Peripartum and postpartum Activin A are significantly elevated in women with preeclampsia. Our hypothesis is that elevated Activin A levels reflect a remediable signal and that reducing postpartum Activin A levels with aspirin therapy will improve (GLS) in preeclamptic patients.
Trial Details
NCT Number NCT04479072
Lead Sponsor University of Chicago
Conditions
(from sponsor)		 Preeclampsia Postpartum
Related terms Cardiovascular Diseases, Hypertension, Pre-Eclampsia
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov